STOCK TITAN
  1. Home
  2. CNST

Constellation Pharmaceuticals Stock Price, News & Analysis

CNST NASDAQ

Company Description

Constellation Pharmaceuticals (NASDAQ: CNST) is a publicly traded research and development in biotechnology company in the Professional, Scientific, and Technical Services sector.

CNST stock has gained 19.0% over the past year.

This page provides a comprehensive overview of CNST stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart
$—
0.00%
0.00
Last updated:
+19.01%
Performance 1 year
$0.0
Market Cap
47.9M
Shares outstanding

Constellation Pharmaceuticals (CNST) stock. Over the past 12 months, the stock has gained 19.0%.

Latest News

View All
—

MorphoSys to Complete Transformational Acquisition of Constellation Pharmaceuticals, Bolstering Its Position in Hematology-Oncology

acquisition
+0.36%

MorphoSys Announces Expiration of the Hart-Scott-Rodino Waiting Period for Acquisition of Constellation Pharmaceuticals

acquisition
+0.30%

Constellation Pharmaceuticals Provides an Update from the Ongoing MANIFEST Study of Pelabresib

0.00%

Constellation Pharmaceuticals Presents Phase 1 Data for CPI-0209 at ASCO Annual Meeting

clinical trial
+65.86%

MorphoSys to Acquire Constellation Pharmaceuticals

acquisition
+2.17%

Constellation Pharmaceuticals to Participate in Jefferies Virtual Healthcare Conference

conferences

Constellation Pharmaceuticals has 10 recent news articles. Of the recent coverage, 4 articles coincided with positive price movement and 4 with negative movement. Key topics include acquisition, clinical trial, conferences, earnings. View all CNST news →

SEC Filings

View All

No SEC filings available for CNST.

Financial Highlights

View Full Financials
—
Revenue (TTM)
—
Net Income (TTM)
—
Diluted EPS (TTM)
—
Operating Cash Flow
—
Net Profit Margin
—
Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months

CNST Company Profile & Sector Positioning

Constellation Pharmaceuticals (CNST) operates in the Research and Development in Biotechnology industry within the broader Professional, Scientific, and Technical Services sector and is listed on the NASDAQ.